Regular ArticleInvolvement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in NK Cell-Mediated and IFN-γ-Dependent Suppression of Subcutaneous Tumor Growth
References (29)
- et al.
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Blood
(2001) Tumor immunology: The glass is half full
Immunity
(1998)Biology of natural killer cells
Adv. Immunol.
(1989)- et al.
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Nature
(2001) - et al.
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Int. Immunol.
(2001) - et al.
Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
Eur. J. Immunol.
(1999) - et al.
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
J. Exp. Med.
(2000) - et al.
Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
Eur. J. Immunol.
(2001) - et al.
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
Nat. Med.
(2001) - et al.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
J. Exp. Med.
(2001)
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
Nat. Med.
(1999)
Safety and antitumor activity of recombinant soluble Apo2 ligand
J. Clin. Invest.
(1999)
Role of NK cells in tumor growth and metastasis in beige mice
Nature
(1980)
Perforin dependence of natural killer cell-mediated tumor control in vivo
Eur. J. Immunol.
(1995)
Cited by (129)
TRAIL and IP-10 dynamics in pregnant women post COVID-19 vaccination: associations with neutralizing antibody potency
2024, Frontiers in Cellular and Infection MicrobiologyLow-dose total body irradiation enhances systemic anti-tumor immunity induced by local cryotherapy
2023, Journal of Cancer Research and Clinical OncologyHarnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
2023, Cell Death and Differentiation
- 1
To whom correspondence and reprint requests should be addressed. Fax: 81-3-3813-0421. E-mail: [email protected].
Copyright © 2001 Elsevier Science (USA). All rights reserved.